S Roze

Health‐economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK

S Roze, William J. Valentine, Katerina Zakrzewska et al. · Diabetic Medicine · 2005 · 95 citations

Health‐economic analysis of real‐time continuous glucose monitoring in people with Type 1 diabetes

S Roze, Rhodri Saunders, Arno Brandt et al. · Diabetic Medicine · 2014 · 40 citations

An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting

Andrew Palmer, Lieven Annemans, S Roze et al. · Journal of Human Hypertension · 2004 · 35 citations

Diabetes Management, Renal Function, Health Economics +10

Insulin therapy in type 2 diabetes patients failing oral agents: cost‐effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US*

Joshua Ray, William J. Valentine, S Roze et al. · Diabetes Obesity and Metabolism · 2006 · 29 citations

Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark

S Roze, Simona de Portu, Jayne Smith‐Palmer et al. · Diabetes Research and Clinical Practice · 2017 · 24 citations

Type 1, Sensor-augmented Pump Therapy, Primary Care +9